GPT Healthcare Limited has announced a strategic appointment to enhance its investor relations capabilities. The healthcare company has engaged MUFG Intime India Private Ltd as its investor relations agency, marking a significant step toward strengthening its capital market presence.

Appointment Details

The company has formally appointed MUFG Intime India Private Ltd to provide investor relations advisory services, with the engagement becoming effective from January 1, 2026. This appointment was announced through a regulatory filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Strategic Objectives

The appointment is designed to achieve multiple strategic objectives for GPT Healthcare Limited. The company aims to strengthen its investor communication framework, enhance transparency in its operations, and improve its overall visibility in the capital markets. These initiatives are expected to facilitate better engagement with existing and potential investors.

Communication Infrastructure

As part of this investor relations enhancement initiative, GPT Healthcare Limited has established dedicated communication channels for investor engagement. The company has designated ir@gptgroup.co.in as the specific email address for all investor-related queries, concerns, and requests. This centralized communication approach is intended to streamline investor interactions and ensure prompt responses to stakeholder inquiries.

Regulatory Compliance

The announcement demonstrates GPT Healthcare Limited's commitment to maintaining robust corporate governance standards and regulatory compliance. The appointment was made in accordance with Regulation 30 of the SEBI Listing Regulations, ensuring full transparency with stock exchanges and investors. The company has also made this information available on its website at www.ilshospitals.com , further emphasizing its commitment to transparent communication.

This strategic move reflects GPT Healthcare Limited's focus on enhancing its investor relations capabilities and maintaining strong relationships with the investment community through professional advisory services.

GPT Healthcare Limited , a prominent healthcare provider in Eastern India, has reported a 12.5% year-on-year increase in revenue for the second quarter of fiscal year 2026, reaching INR 118.9 crores. The company also announced plans for expansion, including signing a Memorandum of Understanding (MOU) for a new hospital in Jamshedpur.

Financial Highlights

• Revenue from operations stood at INR 118.90 crores, up 12.5% year-on-year
• EBITDA for Q2 FY26 was INR 24.10 crores, with a margin of 20%
• Profit After Tax (PAT) came in at INR 10.60 crores, with a margin of 8.8%

The company's EBITDA saw a 10% year-on-year decrease, primarily due to initial losses of approximately INR 3 crores related to the new hospital in Raipur.

Operational Performance

GPT Healthcare has shown improvements in key operational metrics:

• Average Length of Stay (ALOS) improved to 3.49 days as of September 30, 2025
• Average Revenue Per Occupied Bed (ARPOB) stood at INR 38,376
• Bed occupancy across the network was at 44.7%

Notably, about 92% of the company's business continues to come from cash and insurance patients, reflecting the strength of its neighborhood tertiary care model.

Hospital-wise Performance

Expansion Plans

GPT Healthcare has signed an MOU for a new 150-bed hospital in Jamshedpur, with an estimated investment of INR 70 crores. The facility is expected to be commissioned by the end of Q3 FY27, furthering the company's goal of becoming a 1,000-bed hospital chain over the next two years.

Future Outlook

The company expects:

• Raipur hospital to achieve EBITDA breakeven in 12 to 15 months
• An overall ARPOB growth of 5% to 6% through rate revisions and changes in case mix
• EBITDA margins of around 20% to 21% for FY26, including initial losses from the Raipur hospital

Anurag Tantia, Executive Director of GPT Healthcare, stated, "We remain firmly committed to our goal of becoming a 1,000-bed hospital chain over the next two years. This target reflects our broader vision of scaling up operations and bringing quality healthcare to more communities, especially in the underserved regions of Eastern India."

GPT Healthcare continues to focus on expanding its presence in Tier 2 cities, exploring both acquisition and greenfield opportunities in locations such as Varanasi, Patna, and Cuttack.

As the company navigates challenges in new markets and works towards its expansion goals, it remains focused on delivering quality healthcare services and improving patient outcomes across Eastern India.